Första AP-fonden’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.04M | Buy |
24,200
+1,200
| +5% | +$151K | 0.02% | 474 |
|
2025
Q1 | $3.15M | Sell |
23,000
-18,300
| -44% | -$2.5M | 0.02% | 467 |
|
2024
Q4 | $6.32M | Buy |
41,300
+13,200
| +47% | +$2.02M | 0.04% | 350 |
|
2024
Q3 | $5.45M | Buy |
28,100
+3,400
| +14% | +$659K | 0.04% | 375 |
|
2024
Q2 | $5.73M | Sell |
24,700
-3,100
| -11% | -$719K | 0.05% | 327 |
|
2024
Q1 | $5.99M | Buy |
27,800
+3,200
| +13% | +$690K | 0.05% | 353 |
|
2023
Q4 | $6.37M | Sell |
24,600
-3,500
| -12% | -$906K | 0.06% | 297 |
|
2023
Q3 | $7.22M | Buy |
28,100
+1,700
| +6% | +$437K | 0.08% | 261 |
|
2023
Q2 | $7.52M | Sell |
26,400
-1,200
| -4% | -$342K | 0.08% | 265 |
|
2023
Q1 | $7.67M | Sell |
27,600
-5,100
| -16% | -$1.42M | 0.09% | 254 |
|
2022
Q4 | $9.06M | Buy |
32,700
+2,000
| +7% | +$554K | 0.1% | 232 |
|
2022
Q3 | $8.2M | Buy |
30,700
+900
| +3% | +$240K | 0.1% | 227 |
|
2022
Q2 | $6.08M | Buy |
29,800
+4,100
| +16% | +$836K | 0.08% | 298 |
|
2022
Q1 | $5.41M | Sell |
25,700
-3,800
| -13% | -$800K | 0.06% | 344 |
|
2021
Q4 | $7.08M | Sell |
29,500
-1,900
| -6% | -$456K | 0.07% | 322 |
|
2021
Q3 | $8.89M | Sell |
31,400
-6,600
| -17% | -$1.87M | 0.1% | 235 |
|
2021
Q2 | $13.2M | Buy |
38,000
+9,800
| +35% | +$3.39M | 0.15% | 145 |
|
2021
Q1 | $7.89M | Sell |
28,200
-18,100
| -39% | -$5.06M | 0.11% | 219 |
|
2020
Q4 | $11.3M | Buy |
46,300
+13,000
| +39% | +$3.18M | 0.17% | 133 |
|
2020
Q3 | $9.45M | Buy |
33,300
+10,400
| +45% | +$2.95M | 0.2% | 115 |
|
2020
Q2 | $6.13M | Buy |
22,900
+3,100
| +16% | +$829K | 0.16% | 165 |
|
2020
Q1 | $6.26M | Buy |
+19,800
| New | +$6.26M | 0.22% | 124 |
|